skip to Main Content

One of the ways to achieve this is passive data collection to ensure seamless patient journey.

How to make the tools for capturing information on patient dosing behaviour more effective but still provide the best patient journey?

You always need to have the cost-benefit for the user in mind. If you ask the user to perform actions for your solution to work (e.g. enter data) the value created for them has to be substantially higher than the work they do. Solutions are rarely able to deliver value that fully compensates for cost of actions by the user/patient. Therefore, passive data collection is always favoured, but still, you should only collect data that creates substantial value for the user.


How to achieve the best patient outcomes through RWE-driven collaborations?

Have a needs-based approach to your solutions and collaboration. If you ensure to take point-departure in the user needs and inefficiencies in their treatment and have solutions or collaborations that truly address the needs and inefficiencies, you will create value for the user/patient.


What are the challenges of a regulatory affairs professional?/What are the challenges of the regulatory affairs profession?

Do not look for partners to address new technologies. Looks for partners that have complementary assets and technology to address the inefficiencies and needs that you have identified are the most important to address for the patients or users you want to support.

Join Christian at our Digital Therapeutics and Pharma Summit coming up in September where he will deliver a presentation on Improving Patient Outcomes Through Smart Insulin Pens and Open Ecosystems

Christian THEIL LUNDGAARD is a Head of Global Digital Health partnerships, real-world data and strategy in Novo Nordisk. He has background in Corporate Strategy, Commercial Business Development and management consulting (Bain & Company). Cand. Scient. Nanoscience

Back To Top